Max Conway
Professor
Ophthalmology
University of Sydney
Australia
Biography
Attended The University of Sydney Medical School, graduating MB BS with first class honors in 1989 and Doctor of Philosophy in 1998. Advanced Fellowship training in ocular oncology and ophthalmic surgery at The University of Erlangen-Nuernberg, Germany and at The University of California San Francisco, USA. Currently Director of Ocular Oncology Centre Save Sight Institute , The University of Sydney and VMO at St Vincent's Hospital Sydney and Sydney Eye Hospital
Research Interest
Ophthalmology, eye cancer, melanoma, carcinoma, cataract, glaucoma, international ophthalmology
Publications
-
Errington, J., Conway, R., Walsh-Conway, N., Browning, J., Freyer, C., Cebon, J., Madigan, M. (2012). Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. British Journal of Ophthalmology, 96(3), 451-458.
-
Lim, L., Madigan, M., Conway, R. (2013). Conjunctival melanoma: a review of conceptual and treatment advances. Clinical Ophthalmology, 7, 521-531.
-
Quah, X., Conway, R., Madigan, M., Epstein, R. (2014). Emerging strategies for therapeutic targeting of the tumour microenvironment. Cancer Forum, 38(2), 133-137.
